Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Company
>>
Sanofi-Aventis to increase insulins output in China
>> article
Sanofi-Aventis to increase insulins output in China
Editor:lizz Clicks:
0
Date:2010-7-20 17:04:40
Keyword:
Sanofi Lilly
Healthoo Information:
Sanofi-Aventis to stretch its anti-diabetes drugs product line in China
UserLogin
UserName:
Password:
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Waterstone signed diabetes drug contract with SANOFI
Sanofi-Aventis suspected of bribery in China
Eli Lilly sets up innovation center in Dalian
Eli Lilly opened a drug research center&...
Lilly intends to form commercial partnerships...
Eli Lilly plans to introduce over 10&nbs...
Sanofi expects China to be its No. ...
Competition pattern of Duloxetine formula
Eli Lilly to continue venture investment ...
Sanofi-aventis completes acquisition for BMP ...
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map